Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel.
AAPS J. 2013 Apr;15(2):347-53. doi: 10.1208/s12248-012-9445-3. Epub 2012 Dec 15.
The purposes of this study were to assess the efficiency of different nifedipine amorphous solid dispersions (ASDs) in achieving and maintaining supersaturation and to investigate the solubility-permeability interplay when increasing the apparent solubility via ASD formulations. Spray-dried ASDs of nifedipine in three different hydrophilic polymers, hydroxypropyl methylcellulose acetate succinate (HPMC-AS), copovidone, and polyvinylpyrrolidone (PVP), were prepared and characterized by powder X-ray diffraction and differential scanning calorimetry. The ability of these formulations to achieve and maintain supersaturation over 24 h was assessed. Then, nifedipine's apparent intestinal permeability was investigated as a function of increasing supersaturation in the parallel artificial membrane permeability assay model and in the single-pass rat intestinal perfusion model. The efficiency of the different ASDs to achieve and maintain supersaturation of nifedipine was found to be highly polymer dependent; while a dispersion in HPMC-AS enabled supersaturation 20× that of the crystalline aqueous solubility, a dispersion in copovidone enabled 10×, and PVP allowed supersaturation of only 5× that of the crystalline solubility. Nifedipine flux across the intestine from supersaturated solutions was increased, and the apparent intestinal permeability was constant, irrespective of the degree of supersaturation or the polymer being used. In conclusion, while with other solubility-enabling approaches (e.g., surfactants, cyclodextrins, cosolvents), it is not enough to increase the apparent solubility, but to strike the optimal solubility-permeability balance, which limits the chances for successful drug delivery, the amorphous form emerges as a more advantageous strategy, in which higher apparent solubility (i.e., supersaturation) will be readily translated into higher drug flux and overall absorption.
本研究的目的是评估不同硝苯地平无定形固体分散体(ASD)在实现和维持过饱和度方面的效率,并研究通过 ASD 制剂增加表观溶解度时的溶解度-渗透性相互作用。以三种不同亲水性聚合物(羟丙甲纤维素醋酸琥珀酸酯(HPMC-AS)、共聚维酮和聚乙烯吡咯烷酮(PVP))制备并通过粉末 X 射线衍射和差示扫描量热法对硝苯地平喷雾干燥 ASD 进行了表征。评估了这些配方在 24 小时内实现和维持过饱和度的能力。然后,在平行人工膜渗透测定模型和单次通过大鼠肠灌注模型中,研究了硝苯地平表观肠道渗透性随过饱和度增加的情况。发现不同 ASD 实现和维持硝苯地平过饱和度的效率高度依赖于聚合物;尽管 HPMC-AS 分散体使硝苯地平的过饱和度达到晶态水溶解度的 20 倍,但共聚维酮分散体使过饱和度达到 10 倍,而 PVP 仅允许晶态溶解度的过饱和度达到 5 倍。从过饱和溶液中硝苯地平的通量增加,而表观肠道渗透性是恒定的,与过饱和度或使用的聚合物无关。总之,虽然与其他提高溶解度的方法(例如表面活性剂、环糊精、共溶剂)不同,提高表观溶解度还不够,而是要达到最佳的溶解度-渗透性平衡,这限制了成功药物传递的机会,但无定形形式作为一种更有利的策略出现,其中较高的表观溶解度(即过饱和度)将很容易转化为更高的药物通量和整体吸收。